Judith A Wessels

Judith A M Wessels

UNVERIFIED PROFILE

Are you Judith A M Wessels?   Register this Author

Register author
Judith A Wessels

Judith A M Wessels

Publications by authors named "Judith A M Wessels"

30Publications

417Reads

46Profile Views

1PubMed Central Citations

Exploratory analysis of 1936 SNPs in ADME genes for association with busulfan clearance in adult hematopoietic stem cell recipients.

Pharmacogenet Genomics 2013 Dec;23(12):675-83

Departments of aClinical Pharmacy and Toxicology bMedical Statistics and Bioinformatics cHematology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=01213011-201312000-000
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000007DOI Listing
December 2013

Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose.

Drug Metabol Drug Interact 2012 ;27(4):229-34

sion of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/dmdi-2012-0024DOI Listing
June 2013

Differences in 5-hydroxytryptamine-3B haplotype frequencies between Asians and Caucasians.

Int J Biol Markers 2012 Jan-Mar;27(1):34-8

Department of Pharmacy, Ahmad Dahlan University, Yogyakarta - Indonesia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/JBM.2011.8830DOI Listing
August 2012

Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure.

Pharmacogenomics 2012 Jul;13(9):1087-94

Radboud University Nijmegen Medical Center, PO Box 9101, 6500HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.12.83DOI Listing
July 2012

A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?

Eur Heart J 2012 Jan 30;33(2):165-75. Epub 2011 Jul 30.

Department of Cardiology, Leiden University Medical Center, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehr239DOI Listing
January 2012

SNPs and haplotypes in DPYD and outcome of capecitabine--Letter.

Clin Cancer Res 2011 Sep 30;17(17):5833-4; author reply 5835-6. Epub 2011 Aug 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1208DOI Listing
September 2011

Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment.

Pharmacogenet Genomics 2011 Aug;21(8):461-8

Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283478173DOI Listing
August 2011

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.

Eur Heart J 2011 Aug 2;32(15):1909-17. Epub 2011 Jun 2.

Study coordinating Centre, Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO Box 80 082, 3508 TB Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehr116DOI Listing
August 2011

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus.

Pharmacogenomics 2010 Nov;11(11):1517-23

Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.10.121DOI Listing
November 2010

Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle.

Pharmacogenomics 2010 Jul;11(7):1011-7

Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, PO Box 9600, 2300RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.10.87DOI Listing
July 2010

Criteria for the selection of single nucleotide polymorphisms in pathway pharmacogenetics: TNF inhibitors as a case study.

Drug Discov Today 2009 Sep 12;14(17-18):837-44. Epub 2009 Jun 12.

Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2009.05.017DOI Listing
September 2009

Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity.

J Clin Oncol 2009 Sep 10;27(26):4406-12. Epub 2009 Aug 10.

Leiden University Medical Center, Department of Clinical Pharmacy & Toxicology, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.21.7679DOI Listing
September 2009

Genetic markers of treatment response in rheumatoid arthritis.

Curr Rheumatol Rep 2006 Oct;8(5):369-77

Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
October 2006